EN106
EN106 is a potent inhibitor of FEMIB. EN106 is a cysteine-reactive covalent ligand. EN106 disrupts recognition of the key reductive stress substrate of FEM1B, FNIP1. EN106 reduces oxidative stress and rescues high glucose-induced impaired angiogenesis in HUVECs[1][2].
Product Specifications
CAS Number
[757192-67-9]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
E1/E2/E3 Enzyme; NF-κB; Reactive Oxygen Species (ROS) ; SOD
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/en106.html
Purity
99.92
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=C(N(CCC#N)C1=CC=C(OCCO2)C2=C1)CCl
Molecular Formula
C13H13ClN2O3
Molecular Weight
280.71
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lck, NT (Lck, Lsk-t, Proto-oncogene tyrosine-protein kinase LCK, Leukocyte C-terminal Src kinase, Lymphocyte cell-specific protein-tyrosine kinase, p56-LCK) (MaxLight 650) discontinued
